From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves carcinoid syndrome diarrhea treatment

from Pharmacy Times

The FDA has approved a drug for the treatment of carcinoid syndrome diarrhea. Xermelo tablets, in combination with somatostatin analog therapy, are indicated to treat adults with carcinoid syndrome diarrhea that SSA therapy alone has not adequately controlled. Xermelo tablets work by inhibiting the production of serotonin by carcinoid tumors and reducing the frequency of carcinoid syndrome diarrhea. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063